Evicenter
MarkdownMedical informationP&T meetings
Ficerafusp alfa (BCA101)

First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab

Last updated
135 sources

Economic information and modeling reportBudget impact modelResults

Base case

3 evidence topics · 3 sources

Budget impact model of ficerafusp alfa: base-case results

No evidence found.